Abstract: FR-PO519
A Report on Home Hemodialysis Training Time in Patients With Kidney Failure Using the Quanta SC+ Hemodialysis Device
Session Information
- Home Dialysis, Policy, Novel Approaches
November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Dialysis
- 702 Dialysis: Home Dialysis and Peritoneal Dialysis
Authors
- Bamforth, Ryan J., Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
- Whitlock, Reid, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
- Komenda, Paul, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada
- Gorbe, Kelley Lee, Quanta Dialysis Technologies Ltd, Alcester, Warwickshire, United Kingdom
- Pietrafesa, Angela, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
- Bebb, Charlotte, Nottingham University Hospitals NHS Trust, Nottingham, Nottingham, United Kingdom
- Forbes, Suzanne, Barts Health NHS Trust, London, London, United Kingdom
- Ahmed, Saeed, South Tyneside and Sunderland NHS Foundation Trust, South Shields, Tyne and Wear, United Kingdom
- Collister, David Thomas, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
Background
Frequent self-care hemodialysis (HD) in the home setting has several advantages to patients and providers including improved health outcomes, health-related quality of life, patient satisfaction, and lower health care costs. The Quanta SC+ is a contemporary, portable HD device intended to be operated by a broad range of lay users. It was developed in collaboration with experienced home HD patients and human factors engineers with intuitive linear workflows, on-screen step-by-step instructions, and troubleshooting help screens that are easy to navigate. This study is a descriptive report on the home HD training time of first-time users of the Quanta SC+ HD device in the United Kingdom.
Methods
From August 2020 until March 2022, patients on dialysis across 5 sites in the United Kingdom were trained on the Quanta SC+ HD device as part of standard of care for self-care home HD as treatment for their kidney failure. We collected data on the number of total training weeks and sessions to be signed off as safe by a nephrologist and the frequency of training loss. Training time included organizational delays plus needling training time.
Results
As of March 2022, a total of 34 patients completed training on the Quanta SC+ HD device. The mean age of the patients was 52.3 ± 15.1 years, 14 (41.2%) were female. Patients had an average dialysis vintage of 2.6 ± 2.2 years. A total of 9 (26.5%) patients were already on home HD and converted to Quanta SC+ from another device. Training time for these individuals before being signed off as safe by a nephrologist ranged from 2 to 3 weeks (6 to 9 sessions). A total of 25 (73.5%) patients converted to Quanta SC+ from another dialysis modality. The average training time for these individuals before being signed off as safe by a nephrologist was 6 weeks (18 sessions).
Conclusion
A descriptive report of 34 patients with kidney failure who trained for frequent self-care home HD with the Quanta SC+ HD device reported an average training time within expectations set from national kidney organizations with minimal training. These results indicate that the device is user-friendly and intuitive to learn.
Funding
- Commercial Support – Quanta Dialysis Technologies